Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating abemaciclib in combination with other anti-cancer therapies in children and young adults with solid tumors, including neuroblastoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Solid Tumors

Drugs mentioned

• Verzenio (abemaciclib) (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Relapsed Solid Tumor, Refractory Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-06